This inventor holds 1 USPTO granted patent. Top assignee: Agouron Pharmaceuticals, Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Brigitte Leigh Ewanicki: Innovating Indazole Compound Preparation
Introduction
Brigitte Leigh Ewanicki, an accomplished inventor based in Encinitas, California, has made significant contributions to the field of medicinal chemistry. Her expertise in developing innovative methods for preparing indazole compounds has opened new avenues for research and therapeutic applications, particularly in the modulation and inhibition of protein kinases.
Latest Patents
Ewanicki holds a patent related to her research titled "Methods of Preparing Indazole Compounds." This patent discusses innovative methods for synthesizing indazole compounds, which are instrumental as modulators and/or inhibitors of protein kinases. The patent further elaborates on intermediate compounds that are essential for the preparation of these indazole derivatives, demonstrating Ewanicki's impact on advancing medicinal chemistry.
Career Highlights
Brigitte Leigh Ewanicki currently works at Agouron Pharmaceuticals, Inc., where she utilizes her expertise to contribute to cutting-edge pharmaceutical research. Her work is indicative of her commitment to pushing the boundaries of scientific knowledge and developing novel solutions in the field of drug discovery.
Collaborations
Throughout her career, Ewanicki has collaborated with notable colleagues, including Erik Jon Flahive and Annie Judith Kasparian. These partnerships highlight the importance of teamwork within the scientific community in achieving groundbreaking advancements in research and innovation.
Conclusion
Brigitte Leigh Ewanicki represents a remarkable example of innovation within the pharmaceutical industry. Her patent work on indazole compounds not only underscores her inventiveness but also showcases her dedication to enhancing therapeutic options. As science continues to evolve, Ewanicki’s contributions will likely pave the way for further discoveries in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile